Titan Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TTNP and other ETFs, options, and stocks.About TTNP
Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction.
CEOWeei Jye Chay
CEOWeei Jye Chay
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded1992
Founded1992
Employees—
Employees—
TTNP Key Statistics
Market cap6.41M
Market cap6.41M
Price-Earnings ratio-1.05
Price-Earnings ratio-1.05
Dividend yield—
Dividend yield—
Average volume16.70K
Average volume16.70K
High today$4.96
High today$4.96
Low today$4.20
Low today$4.20
Open price$4.20
Open price$4.20
Volume48.25K
Volume48.25K
52 Week high$14.80
52 Week high$14.80
52 Week low$3.03
52 Week low$3.03
People also own
Based on the portfolios of people who own TTNP. This list is generated using Robinhood data, and it’s not a recommendation.